ArticleCancers2022

Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa.

Chuan-Chien Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.